Our companies are made up of insanely talented people driven to change the world — and many of them are hiring. If you have drive, expertise, and a taste for adventure, we wholeheartedly encourage your interest.
AbCellera is an innovative biotechnology company focused on antibody discovery and development. The company partners with leading pharmaceutical firms and emerging biotechs to create first-in-class and best-in-class antibody medicines. Utilizing proprietary technologies and a robust platform, AbCellera accelerates the discovery process, enabling the identification of high-value drug candidates with precision and speed. Their extensive experience in forming strategic partnerships has led to over 100 antibody drug programs, with 14 candidates reaching clinical stages, ultimately impacting over 2 million patients worldwide. AbCellera's commitment to advancing science and improving patient outcomes positions it as a leader in the biotechnology sector.
Agility Robotics is the world’s leading manufacturer of mobile manipulation robots, with its humanoid robot Digit and cloud automation solution Agility Arc. The company focuses on enhancing workflows across various industries, including logistics, manufacturing, and retail. Digit's deployment in commercial settings marks a significant milestone in the humanoid robot industry, demonstrating its ability to perform meaningful work that creates economic value. Agility Robotics differentiates itself through its innovative technology and strategic partnerships, positioning itself as a key player in the automation market.
Alation is a leader in enterprise data intelligence solutions, providing a comprehensive platform that includes data cataloging, governance, and analytics. Their innovative offerings, such as the Behavioral Analysis Engine and AI-powered features, enable organizations to harness their data effectively, ensuring quality and compliance. With 40% of the Fortune 100 relying on Alation, the company has established a strong market position and is recognized for its ability to drive data culture and empower self-service analytics across various industries.
Alchemab Therapeutics is a biotechnology company focused on harnessing the power of the immune system to develop novel antibody therapeutics for hard-to-treat diseases. Their unique platform identifies naturally occurring protective antibodies from resilient individuals, such as long-term cancer survivors, using advanced deep learning and B cell sequencing techniques. With a strong emphasis on neurodegenerative conditions and oncology, Alchemab is building a diverse pipeline of therapeutics, supported by collaborations with patient groups and academic institutions. The company aims to transform drug discovery by leveraging insights from the immune system to create effective treatments for challenging diseases.
Asimov is a synthetic biology company that provides an integrated suite of cells, genes, and software to enable advanced genetic design and manufacture of therapies. Their platform includes engineered host cells, a genetic parts library, and cloud-based design software, allowing clients to develop custom cell lines and optimize genetic constructs. Asimov differentiates itself through its comprehensive approach, combining synthetic biology with computational tools, and has achieved significant traction with partnerships across the biotech industry, including over 25 companies from small biotechs to large pharmaceutical firms. The company is positioned at the forefront of the synthetic biology market, leveraging AI and machine learning to enhance genetic engineering capabilities.
Atomwise is a technology-enabled pharmaceutical company leveraging AI to revolutionize small molecule drug discovery. They have developed a best-in-class AI discovery engine that utilizes deep learning for structure-based drug design, enabling the identification and optimization of novel chemical compounds. Atomwise has validated its technology across various protein types and challenging drug targets, advancing a proprietary pipeline of small-molecule drug candidates. Their approach focuses on transforming drug discovery processes to invent better medicines for patients, positioning them as a leader in the AI-driven pharmaceutical landscape.
Axelar is a cross-chain communication tool developing interoperability software to connect blockchain ecosystems, applications, and users. Axelar Network consists of a protocol suite, tools, and APIs, designed to break down the barriers to cross-chain communication. Axelar enables developers to build on the best platform for their needs whileleveraging the Axelar stack to unlock cross-chain composability and liquidity.
Brimstone is pioneering a decarbonized cement solution that addresses one of the most significant climate challenges. Founded by Cody Finke and Hugo Leandri, the company has developed a breakthrough process that produces ordinary portland cement and supplementary cementitious materials with a significantly reduced carbon footprint. Their technology utilizes carbon-free calcium silicate rock instead of traditional limestone, ensuring that the product remains chemically and physically identical to conventional cement while being cost-competitive at scale. With a focus on transforming the cement industry from a climate problem to a climate hero, Brimstone is poised to make a substantial impact on global CO2 emissions, which account for 7.5% of total emissions from cement production.
Capella Space is an information services company that provides on-demand high-resolution synthetic aperture radar (SAR) Earth observation imagery through a constellation of small satellites. Their advanced SAR technology enables all-weather, day-and-night monitoring, offering precise imagery and rapid access to critical data. Capella's unique capabilities allow for high-cadence revisit rates and flexible collection schedules, making them a leader in the Earth observation market. They cater to various industries, including intelligence, insurance, and disaster response, ensuring timely insights for informed decision-making.
Carbon Health is a tech-enabled healthcare company that provides modern primary and urgent care services through a mobile application. The company differentiates itself by offering easy scheduling, same-day appointments, and a comprehensive virtual care experience without membership fees. With a focus on accessibility, Carbon Health accepts most major insurance plans and has established numerous locations across the United States. The company has gained traction with positive patient feedback and a growing presence in various states, positioning itself as a leader in the urgent care market.
